MedPath

Efficacy of CYTISINE for Smoking Cessation through Downward Titration versus Simplified Three times daily Regimen : Open-label Randomized Clinical Trial

Phase 3
Conditions
Smoking Cessation
Smokers
cytisine,
Smokers ,
Registration Number
TCTR20240711001
Lead Sponsor
Thai Health Promotion Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
120
Inclusion Criteria

1. Over 18 years of age and not over 65 years of age.
2. Current daily cigarette smokers. There is a need to quit smoking at the preparation/contemplation level according to The Trans theoretical Model.
3. Sign the Informed Consent Form.
4. Smoke more than 10 cigarettes per day.
5. If you are a woman of reproductive age and have a chance of becoming pregnant Must be willing to use birth control before participating in the research project. 6. Have a mobile phone that can set reminders and allow the use of telephone reminder methods. For use in evaluating drug compliance of volunteers

Exclusion Criteria

1. Have a congenital disease that may be dangerous from receiving research drugs, such as heart arrhythmia. Coronary artery disease, cancer, chronic kidney disease (creatinine clearance <30 ml/minute), psychiatric disorders such as depression. schizophrenia or patients who also use other types of drugs such as marijuana, amphetamines, etc.
2. Are pregnant or breastfeeding
3. Already being treated with medications to help you quit smoking, including nicotine replacement therapy (NRT), Nortriptyline, Bupropion, Clonidine, and Varenicline.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
continuous smoking abstinence at weeks 4 and 12 verified by self reporting and exhaled carbon monoxide levels at 12 weeks after end of the intervention exhaled carbon monoxide levels (less than7 ppm).
Secondary Outcome Measures
NameTimeMethod
adverse reactions at 12 weeks after end of the intervention Patient reported outcome using a questionnaire interview
© Copyright 2025. All Rights Reserved by MedPath